Clinical Trials · NCT07040592
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Yale University
- Enrollment
- 30
- Start date
- Jan 2026
- Locations
- 1 site, United States
- Primary endpoint
- Proportion of participants who complete enrollment and duration of sessions